Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
Clinical trial NCT03094052 · COMPLETED
Trial details
- NCT number
- NCT03094052
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2022-10-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.